(-0.94%) 5 067.88 points
(-1.06%) 37 980 points
(-1.12%) 15 804 points
(-0.90%) $81.89
(-1.13%) $2.01
(-2.04%) $2 309.50
(-3.49%) $26.70
(-1.79%) $944.30
(0.44%) $0.936
(0.91%) $11.08
(0.46%) $0.800
(0.29%) $93.57
Live Chart Being Loaded With Signals
Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. The company offers diagnostic, therapeutic, and intensive care facilities in a medical center...
Stats | |
---|---|
Šios dienos apimtis | 500.00 |
Vidutinė apimtis | 8.00 |
Rinkos kapitalizacija | 4.85B |
EPS | €2.01 ( 2023-06-30 ) |
Last Dividend | €1.350 ( 2023-08-24 ) |
Next Dividend | €0 ( N/A ) |
P/E | 29.05 |
ATR14 | €0.0310 (0.50%) |
Tūris Koreliacija
Bumrungrad Hospital Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Bumrungrad Hospital Koreliacija - Valiuta/Žaliavos
Bumrungrad Hospital Finansinės ataskaitos
Annual | 2023 |
Pajamos: | €25.38B |
Bruto pelnas: | €12.48B (49.19 %) |
EPS: | €8.81 |
FY | 2023 |
Pajamos: | €25.38B |
Bruto pelnas: | €12.48B (49.19 %) |
EPS: | €8.81 |
FY | 2022 |
Pajamos: | €20.72B |
Bruto pelnas: | €9.62B (46.43 %) |
EPS: | €6.21 |
Financial Reports:
No articles found.
Bumrungrad Hospital Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€1.150 (N/A) |
€0 (N/A) |
€2.35 (N/A) |
€0 (N/A) |
€1.350 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.400 | 2008-04-29 |
Last Dividend | €1.350 | 2023-08-24 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 33 | -- |
Total Paid Out | €36.65 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 4.08 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.74 | |
Div. Directional Score | 9.18 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SNW.DE | Ex Dividend Junior | 2023-05-30 | Annually | 0 | 0.00% | |
CPIA.F | No Dividend Player | 2023-06-29 | Annually | 0 | 0.00% | |
LHOG.F | Ex Dividend Junior | 2023-08-24 | Semi-Annually | 0 | 0.00% | |
185.DE | Ex Dividend Junior | 2023-08-07 | Quarterly | 0 | 0.00% | |
UTDI.DE | Ex Dividend Junior | 2023-05-18 | Annually | 0 | 0.00% | |
ED4.DE | Ex Dividend Junior | 2023-06-29 | Sporadic | 0 | 0.00% | |
NOA3.DE | Ex Dividend Knight | 2023-10-23 | Semi-Annually | 0 | 0.00% | |
ADN1.DE | Ex Dividend Junior | 2023-06-02 | Annually | 0 | 0.00% | |
ZOE.DE | Ex Dividend Knight | 2023-07-20 | Quarterly | 0 | 0.00% | |
GIL.DE | Ex Dividend Junior | 2023-05-15 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.287 | 1.500 | 4.27 | 6.40 | [0 - 0.5] |
returnOnAssetsTTM | 0.237 | 1.200 | 2.08 | 2.50 | [0 - 0.3] |
returnOnEquityTTM | 0.319 | 1.500 | 7.56 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.397 | -1.000 | 6.03 | -6.03 | [0 - 1] |
currentRatioTTM | 4.29 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 4.16 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 0.639 | 1.500 | 7.56 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.00473 | -1.500 | 9.92 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 2 236.39 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 9.62 | 2.00 | 6.79 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 7.40 | 2.00 | 6.30 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.00572 | -1.500 | 9.98 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.501 | 1.000 | 4.98 | 4.98 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.348 | 1.000 | 5.05 | 5.05 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 51.77 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.828 | 0.800 | 7.81 | 6.25 | [0.5 - 2] |
Total Score | 12.62 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 25.71 | 1.000 | 7.50 | 0 | [1 - 100] |
returnOnEquityTTM | 0.319 | 2.50 | 8.43 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 7.40 | 2.00 | 7.53 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.878 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 9.62 | 2.00 | 6.79 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.397 | 1.500 | 6.03 | -6.03 | [0 - 1] |
pegRatioTTM | 0.0775 | 1.500 | -2.82 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.296 | 1.000 | 5.11 | 0 | [0.1 - 0.5] |
Total Score | 5.74 |
Bumrungrad Hospital
Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. The company offers diagnostic, therapeutic, and intensive care facilities in a medical center. Its outpatient clinics/centers include allergy, arrhythmia, behavioral health, breastfeeding, breast care, children, dental, diabetes, diagnostic, dialysis, digestive disease, emergency, eye, fertility and IVF, health screening, hearing and balance, heart valve, cancer, hyperbaric oxygen therapy, hypertension, joint replacement, liver, memory, men, nephrology, neuroscience, new life healthy aging, orthopedic, Parkinson's disease and movement disorders, perinatal, physical therapy and rehabilitation, plastic surgery, pulmonary, refractive surgery, robotic scoliosis and surgery, skin, sleep lab, spine, sports medicine and lifestyle, surgical, travel medicine, urology, vitalife, and women's, as well as ear, nose, and throat centers. In addition, the company is involved in the real estate assets holding activities; provision of clinical research services; distribution of pharmaceutical and medical goods in specialized stores; operation of personnel development and training center for healthcare services; and patient referral service business. It operates 580 beds and approximately 56 clinics/centers. The company was founded in 1980 and is headquartered in Bangkok, Thailand.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.